Effects of Acupuncture on Abdominal Pain-related Intestinal Flora in Patients With Crohn's Disease - Trial NCT06375382
Access comprehensive clinical trial information for NCT06375382 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai Institute of Acupuncture, Moxibustion and Meridian and is currently Completed. The study focuses on Crohn Disease. Target enrollment is 64 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Timeline & Enrollment
N/A
Mar 01, 2015
Mar 31, 2024
Primary Outcome
Abdominal pain remission rate
Summary
Crohn's disease is an intestinal inflammatory disease, causing abdominal pain, diarrhea and
 other symptoms. The intestinal flora disorder is closely related to the occurrence and
 development of Crohn's disease. Acupuncture can induce remission of Crohn's disease during
 mild to moderate active period, improve clinical symptoms such as abdominal pain. This study
 is to screen the intestinal bacteria related to abdominal pain in CD, and explore the effects
 of acupuncture on the intestinal flora related to abdominal pain in CD patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06375382
Non-Device Trial